Cancer cells can escape immune recognition via insufficient expression of peptides presented by the MHC, because HLA-mediated presentation of immunogenic cancer peptides class I is a prerequisite of a successful antitumor immune response [17]. The gene discussed is HLA-C; the disease is cancer.